Drugs / JNJ-67896049
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04435782 | Jul 2021 → Jul 2023 | pulmonary arterial hypertension | Actelion | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JNJ-67896049 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04435782 ↗ |